Isabel Padilla
Internal Medicine · Katy, TXNPI 1447644950
Payments from drug & device makers
Across 94 payments — averaging $22.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$560
- AstraZeneca$415
- GSK$251
- Lilly USA, LLC$173
- Inspire Medical Systems, Inc.$101
- Amgen$65
- plus $567 from 17 others
What the payments were for
- Food & beverage$2,131100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 15 | $560 |
| AstraZeneca | 19 | $415 |
| GSK | 17 | $251 |
| Lilly USA, LLC | 10 | $173 |
| Inspire Medical Systems, Inc. | 1 | $101 |
| Amgen | 4 | $65 |
| Bayer | 3 | $62 |
| Pfizer | 2 | $57 |
| Astellas Pharma US Inc | 2 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| AbbVie | 3 | $46 |
| Genentech USA, Inc. | 2 | $41 |
| Exact Sciences | 2 | $35 |
| Boehringer Ingelheim | 1 | $32 |
| Pulmonx Corporation | 1 | $32 |
| Azurity Pharmaceuticals, Inc. | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Johnson & Johnson | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Abbott | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,131 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 49 | $887 |
| Rosuvastatin Calcium | 22 | $692 |
| Omeprazole | 20 | $527 |
| Escitalopram Oxalate | 11 | $359 |
| Alendronate Sodium | 17 | $337 |
| Amlodipine Besylate | 31 | $301 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $236 |
| Pantoprazole Sodium | 13 | $231 |
| Lisinopril | 17 | $222 |
| Losartan Potassium | 13 | $195 |
| Levothyroxine Sodium | 39 | $162 |
| Methylprednisolone | 16 | $138 |
| Metoprolol Tartrate | 15 | $137 |
| Metformin Hcl | 14 | $134 |
| Hydrochlorothiazide | 17 | $83 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Katy
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
- Nicholas ShortHouston$17.6M
- Salma SaigerMesquite$16.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.